Spotlight Pathology

Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.

Health and bio

Spotlight Pathology has no funding amount on record yet; its latest known round is Seed (Mar 2026). Recent Funding first saw it on October 2, 2026.

Founders and team

• RB
  Richard Byers Founder

  source: crunchbase.com

Raise history

1. March 11, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related ai companies

• GGood Tape$600K · Oct 2, 2026
• OOptimizeGEO.ai$80M · Oct 1, 2026
• 11club AI$2.2M · Oct 1, 2026
• PPredictive AIOct 1, 2026
• JJAOPS$260M · Oct 1, 2026
• EestaieOct 1, 2026
• OOpensOct 1, 2026
• KKeepsake Family HistoryOct 1, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/spotlight-pathology.